Iodinated contrast agents do not accelerate residual renal function decline in PD patients
Pippa Murdie
This article has no abstract so we have provided the first paragraph of the full text.
Preservation of residual renal function has been shown to be important for peritoneal dialysis (PD) to remain effective over the long term. Administration of contrast medium to PD patients has been associated with adverse effects, including increased serum creatinine levels and increased risk of acute and chronic end-stage renal failure. Several factors, including old age, dehydration and diabetes, have been reported to put patients at further increased risk. Moranne et al. report that, with adequate hydration, stable PD patients do not exhibit accelerated decline following iodinated contrast medium administration (ICMA).
Full text of this article is available with one of the following:
- Membership of the International Society of Nephrology. If already a member, please login. If not please join the Society now
- Personal subscription Purchase your own personal subscription to this journal. Already a subscriber? Please login for immediate access.
- 7 day single article pass for US$18 In order to purchase this article you must be a registered user. Please register or login above.
- Site licence Learn more about institutional site licences
Current Subscribers
Please log in to access the full text article using the login box at the top of the page.
MORE ARTICLES LIKE THIS
These links to content published by NPG are automatically generated.
